Citation Impact

Citing Papers

Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe
2018 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Digitalization to achieve sustainable development goals: Steps towards a Smart Green Planet
2021 Standout
Paper-based microfluidic point-of-care diagnostic devices
2013 Standout
Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C-Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial
2009
A Smartphone App (AfyaData) for Innovative One Health Disease Surveillance from Community to National Levels in Africa: Intervention in Disease Surveillance
2017
Sense and nonsense in the process of accreditation of a pathology laboratory
2015
Elevated Pre–Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection
2017 StandoutNobel
Lipid nanoparticles for mRNA delivery
2021 Standout
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
2017 Standout
Enhancing the performance of a point-of-care CD4+ T-cell counting microchip through monocyte depletion for HIV/AIDS diagnostics
2009
Lab-on-a-chip devices for global health: Past studies and future opportunities
2006
Commercialization of microfluidic point-of-care diagnostic devices
2012
Digital technologies in the public-health response to COVID-19
2020 Standout
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Microglial cell origin and phenotypes in health and disease
2011 Standout
Rational design of gene‐based vaccines
2005
High prevalence of the CYP2B6 516G→T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe
2007
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study
2015 StandoutNobel
REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
2018
The Next Generation of Sepsis Clinical Trial Designs
2014
A Microchip Approach for Practical Label-Free CD4+ T-Cell Counting of HIV-Infected Subjects in Resource-Poor Settings
2007
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
Patterned Paper as a Platform for Inexpensive, Low‐Volume, Portable Bioassays
2007 Standout
A microfluidic device for practical label-free CD4+ T cell counting of HIV-infected subjects
2006
New Approaches to Detection and Identification of <I>Rickettsia africae</I> and <I>Ehrlichia ruminantium</I> in <I>Amblyomma variegatum</I> (Acari: Ixodidae) Ticks From the Caribbean
2009
Point-of-care tests for diagnosing infections in the developing world
2010
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
2009 StandoutNobel
Cause‐Specific Mortality and the Contribution of Immune Reconstitution Inflammatory Syndrome in the First 3 Years after Antiretroviral Therapy Initiation in an Urban African Cohort
2009
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Challenges and opportunities for the implementation of virological testing in resource‐limited settings
2012
Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials
2011
Myocarditis
2011 Standout
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Novel approaches for vaccine development
2021
CRISPR–Cas12-based detection of SARS-CoV-2
2020 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
A multiplexed RT-LAMP assay for detection of group M HIV-1 in plasma or whole blood
2018
Immediate Blood Draw for CD4+ Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care
2016
The present and future role of microfluidics in biomedical research
2014 StandoutNature
Graphene Oxide: Intrinsic Peroxidase Catalytic Activity and Its Application to Glucose Detection
2010 Standout
Treatment 2.0
2012
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer
2014 StandoutNobel
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
2006 Nature
A colloidal quantum dot spectrometer
2015 StandoutNatureNobel
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007 Standout
Nano/Microfluidics for diagnosis of infectious diseases in developing countries
2009
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Advances in CD4 cell enumeration in resource-poor countries
2007
The Immunogenicity of Adenovirus Vectors Limits the Multispecificity of CD8 T-cell Responses to Vector-encoded Transgenic Antigens
2008
True outcomes for patients on antiretroviral therapy who are lost to follow-up in Malawi
2007
Requirements for high impact diagnostics in the developing world
2006 StandoutNature
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Advanced HIV Disease at Entry into HIV Care and Initiation of Antiretroviral Therapy During 2006-2011: Findings From Four Sub-Saharan African Countries
2013
Current understanding of HIV-associated neurocognitive disorders pathogenesis
2011
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Early Mortality in Adults Initiating Antiretroviral Therapy (ART) in Low- and Middle-Income Countries (LMIC): A Systematic Review and Meta-Analysis
2011
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer
2010
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
Borrelia,Ehrlichia, andRickettsiaspp. in Ticks Removed from Persons, Texas, USA
2010
A Molecular Biomarker to Diagnose Community-acquired Pneumonia on Intensive Care Unit Admission
2015
Trends in CD4 Count at Presentation to Care and Treatment Initiation in Sub-Saharan Africa, 2002–2013: A Meta-analysis
2014
Active Particles in Complex and Crowded Environments
2016 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila.
2001 Standout
AASLD guidelines for treatment of chronic hepatitis B
2015
Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities
2011
Cowdria ruminantium infection in ticks in the Kruger National Park
1999
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Lanthanide Luminescence for Biomedical Analyses and Imaging
2010 Standout
Emergence of colloidal quantum-dot light-emitting technologies
2012 StandoutNobel
The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.
2009
Diagnosing COVID-19: The Disease and Tools for Detection
2020 Standout
Understanding Wax Printing: A Simple Micropatterning Process for Paper-Based Microfluidics
2009 Standout
Endothelial barrier dysfunction in septic shock
2014
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines
2007 StandoutNobel
Diagnostics for the Developing World: Microfluidic Paper-Based Analytical Devices
2009 Standout
Engineering Protein Switches for Rapid Diagnostic Tests
2020
Interventions for enhancing medication adherence
2014 Standout
The oral mucosa immune environment and oral transmission of HIV/SIV
2013
Microfluidic CD4 + and CD8 + T Lymphocyte Counters for Point-of-Care HIV Diagnostics Using Whole Blood
2013
Rickettsia africaein the West Indies
2006
Point-of-Care Diagnostics for Global Health
2008 Standout
Viral Tropism, Fitness and Pathogenicity of HIV-1 Subtype C
2010
Simultaneous Neutralization and Innate Immune Detection of a Replicating Virus by TRIM21
2013
Age Dependence of Adenovirus-Specific Neutralizing Antibody Titers in Individuals from Sub-Saharan Africa
2006
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
2008
HIV VACCINES
2005
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
2022 StandoutNobel
Simple Telemedicine for Developing Regions: Camera Phones and Paper-Based Microfluidic Devices for Real-Time, Off-Site Diagnosis
2008 Standout
Update on Tick-Borne Rickettsioses around the World: a Geographic Approach
2013 Standout
Emerging Droplet Microfluidics
2017 Standout
Inkjet-Printed Microfluidic Multianalyte Chemical Sensing Paper
2008
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel

Works of Trevor Peter being referenced

Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing
2011
COMPARISON OF EFFICACY OF AMERICAN AND AFRICANAMBLYOMMATICKS AS VECTORS OF HEARTWATER (COWDRIA RUMINANTIUM) INFECTION BY MOLECULAR ANALYSES AND TRANSMISSION TRIALS
2000
Challenges in implementing CD4 testing in resource-limited settings
2008
Antiretroviral Concentrations in Breast‐Feeding Infants of Women in Botswana Receiving Antiretroviral Treatment
2005
Impact of Laboratory Accreditation on Patient Care and the Health System
2010
Point-Of-Care p24 Infant Testing for HIV May Increase Patient Identification despite Low Sensitivity
2017
Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study
2011
Highly Active Antiretroviral Therapy Started during Pregnancy or Postpartum Suppresses HIV‐1 RNA, but Not DNA, in Breast Milk
2005
Accurate Early Infant HIV Diagnosis in Primary Health Clinics Using a Point-of-Care Nucleic Acid Test
2014
A Microchip CD4 Counting Method for HIV Monitoring in Resource-Poor Settings
2005
How Point-of-Care Testing Could Drive Innovation in Global Health
2013
Increasing Risks of Introduction of Heartwater onto the American Mainland Associated with Animal Movements
2002
GROWTH OF COWDRIA RUMINANTIUM IN TISSUE CULTURE ENDOTHELIAL CELL LINES FROM WILD AFRICAN MAMMALS
1998
DEMONSTRATION OF A CARRIER STATE FOR COWDRIA RUMINANTIUM IN WILD RUMINANTS FROM AFRICA
1998
Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein
2005
The Need for Standardization in Laboratory Networks
2009
HIV-1 Subtype C Drug-Resistance Background among ARV-Naive Adults in Botswana
2005
Initial Response to Highly Active Antiretroviral Therapy in HIV-1C-Infected Adults in a Public Sector Treatment Program in Botswana
2005
Rankless by CCL
2026